Contact us
EN
FR
About
us
Our history
Expertise
Management
Board of directors
Scientific advisors
Rare diseases policy
Transparency
Pioneering
Science
Concept
Pipeline
Clinical
programs
MPS IIIA
GM1 gangliosidosis
Patients and
families
MPS IIIA
GM1 gangliosidosis
Links and resources
Partnering
Investors
Welcome
Stock Information
Press Releases
Events
AMF Regulated Information
Annual General Assembly 2017
Annual General Assembly 2018
Corporate Presentation
Investor Contacts
Media
Home
> Press Releases
Press Releases
Latest tweet
Lysogene announces the nomination of Dr Ralph Laufer as Chief Scientific Officer and member of the executive team https://t.co/KGBaL8l4Vb
arrow-left
arrow-right
calendar
contact
download
facebook
linkedin
location
play
reset
rss
twitter
youtube
